SARS-CoV-2 Variants: Evading the Immune System
The COVID-19 pandemic, caused by the novel SARS-CoV-2 coronavirus , has ravaged the globe, infecting over 145 million people and causing over 3 million deaths as of the time of this article. Ending the pandemic will require a combination of effective interventions, including therapeutics, diagnostics, and vaccines. Several monoclonal antibody therapeutics have received emergency use authorization, and a number of vaccines have been devel...
Coronavirus Services
Biochemical Screening
Cell-Based Services
Cell Lines /CRISPR
Protein Binding Studies/BLI
BPS Bioscience has developed innovative proteins , cell lines , lentiviruses , and assay kits , to enable a wide range of preclinical activities for investigating potential COVID-19 antiviral drugs. These kits and services aim to rapidly advance drugs into the clinic by screening for compounds that prevent the ...
Screening and Profiling Services
Evaluate lead compounds with our biochemical and cell-based screening services to identify specific inhibitors or activators. Save time by letting us screen your small molecules or biologics of interest against our unique assay panels or determine IC 50 values. With our portfolio of > 600 assays available as a service, we’re here to help advance your drug discovery program.
Our biochemical-based inhibitor...
SARS-CoV-2 Coronavirus Variants
The COVID-19 pandemic, caused by the novel SARS-CoV-2
coronavirus , has ravaged the globe, infecting over 450 million people and causing over 6 million deaths as
of early 2022. The recent emergence of new SARS-CoV-2 variants is a severe concern, especially omicron and delta
variants, as many of these mutations occur within the Spike protein and appear to increase transmissibility and
infectivity. The graphics belo...
